-
Gregory K Parker, PA-C
Gregory K Parker, PA-C specializing in Orthopedics, Sports Medicine
-
A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum-STUDY00004829
To compare the effectiveness of two suicide prevention strategies tailored for autistic individuals: the Safety Planning Intervention tailored for...
-
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood unios (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications-PIROSTUDY14135
Iron Mountain Box # 676416053
-
A Long-term Observational Study Evaluating Sarepta Therapeutics, Inc's Exon-Skipping Therapies in Patients with Duchenne Muscular Dystrophy under Conditions of Routine Clinical Practice-STUDY00002656
An observational study that is designed to collect available data on DMD patients receiving an FDA approved exon skipping drug in routine clinical...
-
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection-STUDY00005310
People with cystic fibrosis (CF) often have lung infections caused by the bacteria, Pseudomonas aeruginosa (PsA), which require treatment with...
-
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE III TRIAL TO ASSESS THE SAFETY AND EFFICACY OF VIASKIN® PEANUT IN PEANUT-ALLERGIC YOUNG CHILDREN 1-3 YEARS OF AGE-STUDY00001321
To learn more about this study, please email the study team member listed below.
-
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in
Prader-Willi Syndrome-STUDY00004583
This is a 12-week, multicenter, randomized, double-blind,
placebo-controlled, parallel-group study comparing carbetocin
nasal spray 3.2 mg TID...
-
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years with Stage 5-STUDY00002090
THis Phase 3 multi center study will evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution for the
treatment of...
-
Assessment of Systemic Ventricular Volume and Function using the VentriPoint Medical System in Patients with Single Ventricle Congenital Heart Disease; A Comparison to cMRI-STUDY00004474
This is a prospective single site observational study enrolling 50 patients with SV-CHD, referred for clinically indicated CMR. In conjunction to...
-
Bedside Evaluation of Gut Perfusion to Support Intestinal Health in Infants with Congenital Heart Disease-STUDY00003270
To learn more about this study, please email the study team member listed below.